CTMXNasdaq United States
Market cap
$753.252 M
$3.46 +2.67%
Close of 7 Aug 2026
Revenue
$76.2M
#2611 by revenue
Earnings
-$17.4M
Loss-making
Shares outstanding
217,899,284
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for CytomX Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.